Supplemental material
Open access
5,064
Views
63
CrossRef citations to date
0
Altmetric
Report
Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies
Rajkumar GanesanBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USACorrespondence[email protected] [email protected]
http://orcid.org/0000-0002-3431-9664
, http://orcid.org/0000-0002-3431-9664
Ernest L. RaymondBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USA
, Detlev MennerichBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USA
, Joseph R. Woska Jr.Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USA
, Gary CavinessBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USA
, Christine GrimaldiBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USA
, Jennifer AhlbergBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USAhttp://orcid.org/0000-0002-2892-4163
, Rocio PerezBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USA
, Simon RobertsBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USAhttp://orcid.org/0000-0002-5743-3769
, Danlin YangBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USA
, Kavita JerathBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USA
, Kristopher TruncaliBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USA
, Lee FregoBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USA
, Eliud SepulvedaBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USA
, Priyanka GuptaBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USAhttp://orcid.org/0000-0001-6483-3069
, Su-Ellen BrownBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USA
, Michael D. HowellBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USA
, Keith A. CanadaBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USA
, Rachel Kroe-BarrettBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USAhttp://orcid.org/0000-0003-1413-1223
, Jay S. FineBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USA
, Sanjaya SinghBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USAhttp://orcid.org/0000-0002-9119-7966
& M. Lamine MbowBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT., USACorrespondence[email protected] [email protected]
show all
Pages 1143-1154
|
Received 04 Apr 2017, Accepted 29 Jun 2017, Published online: 28 Aug 2017
Related Research Data
Psoriasiform dermatitis is driven by IL-36–mediated DC-keratinocyte crosstalk
Source:
American Society for Clinical Investigation
Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis
Source:
Elsevier BV
Tailoring kinetics of antibodies using focused combinatorial libraries.
Source:
Humana Press
Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation.
Source:
Rockefeller University Press
Mutation analysis of IL36RN in a Chinese Daur family with generalized pustular psoriasis
Source:
John Libbey Eurotext
Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents.
Source:
Springer Science and Business Media LLC
A new nomenclature for IL-1-family genes.
Source:
Elsevier BV
IL-36α expression is elevated in ulcerative colitis and promotes colonic inflammation.
Source:
Springer Science and Business Media LLC
Mutation analysis of the IL36RN gene in Chinese patients with generalized pustular psoriasis with/without psoriasis vulgaris.
Source:
Elsevier BV
Interleukin (IL)-1F6, IL-1F8, and IL-1F9 Signal through IL-1Rrp2 and IL-1RAcP to Activate the Pathway Leading to NF-κB and MAPKs
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee
Source:
Springer Science and Business Media LLC
IL-1RL2 and Its Ligands Contribute to the Cytokine Network in Psoriasis
Source:
The American Association of Immunologists
IL-1 family expression in psoriasis keratinocytes
Source:
Wiley
Mutations in IL36RN in Patients with Generalized Pustular Psoriasis
Source:
Elsevier BV
Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity.
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
Deletion of the diploid dihydrofolate reductase locus from cultured mammalian cells
Source:
Elsevier BV
Correspondence
Source:
Wiley
IL36RN mutations underlie impetigo herpetiformis.
Source:
The Society for Investigative Dermatology, Inc.
The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.
Source:
Elsevier BV
Alterations of plasma inflammatory biomarkers in the healthy and chronic obstructive pulmonary disease patients with or without acute exacerbation
Source:
Elsevier BV
What's in a Name?
Source:
American Medical Association (AMA)
Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations
Source:
Wiley
Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients
Source:
Springer Science and Business Media LLC
Loss of IL36RN Function Does Not Confer Susceptibility to Psoriasis Vulgaris
Source:
Elsevier BV
Mutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustular psoriasis.
Source:
Wiley
Correspondence
Source:
Wiley
Disrupting the IL-36 and IL-23/IL-17 loop underlies the efficacy of calcipotriol and corticosteroid therapy for psoriasis
Source:
HAL CCSD
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.